Close Menu

carrier screening

Cheaper testing is enabling more widespread carrier screening of prospective parents.

The company's goal is to transition from a one-test provider to a full-service genetic testing company in the reproductive health and potentially other markets.

The partnership will enable Good Start to offer IviGen products and services to in vitro fertilization specialists and women's health professionals in the US and Canada.

NEW YORK (GenomeWeb) — Startup preconception genetic testing company GenePeeks has officially launched its sperm donor screening service, Matchright, with two partner sperm banks.

Gene by Gene will later this year debut a genetic disease carrier screening service focused on Jewish populations in the US.

Recombine is a relatively new genetic testing company that, for the moment, has a genetic disease carrier detection screening test called CarrierMap as its flagship offering.

NEW YORK (GenomeWeb News) – Genetic testing startup Recombine said yesterday that it has raised $3.3 million in a Series A financing.

NEW YORK (GenomeWeb News) - Good Start Genetics said today that it has signed a coverage agreement with Tufts Health Plan for its GoodStart Select sequencing-based carrier screening test.

This is the second in a series of profiles of centers awarded grants this year under NHGRI's Clinical Sequencing Exploratory Research program.

NEW YORK (GenomeWeb News) – Good Start Genetics today said that it has received a clinical lab permit from the New York State Department of Health, enabling the firm to offer its GoodStart Select carrier screening tests to in vitro fertilization and other reproductive health physicians in the sta

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.